Intervention: Antivirals

A class of medications used to treat viral infections

Drysdale 3

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Primary care
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

Gentile

Italy
|
2023-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Sotrovimab

Rinaldi

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Molnupiravir

Basoulis

Greece
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir

De Vito

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Patel

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Community
  • Primary care
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

ECRAID-EU-RECOVERY

France Italy The Netherlands Belgium Estonia Portugal Romania Spain Sweden
|
2020
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Influenza
  • Avian Influenza
  • Pharmacological intervention
  • Antivirals
  • Corticosteroid
  • Baloxavir
  • Oseltamivir

Villamarin

Spain
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

UNITY

Argentina Brazil Switzerland
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

Sobral-Costas

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Cidofovir

Platinium

United Kingdom
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

PanoramicNOR

Norway
|
2023-2026
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir